Peter M A Groenen (Peter Groenen)

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 3

Top Topics

Network Analysis

Amyotrophic Lateral Sclerosis

Protein Protein

Top Venues

British journal of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Klaus Højgaard Jensen, Anna Katharina Stalder, Rasmus Wernersson, Tim-Christoph Roloff-Handschin, Daniel Hvidberg Hansen, Peter M A Groenen
A molecular view of amyotrophic lateral sclerosis through the lens of interaction network modules. PloS one 17 (5) (2022)
Marion Anliker-Ort, Jasper Dingemanse, Hervé Farine, Peter M A Groenen, Rüdiger Kornberger, John van den Anker, Priska Kaufmann
Multiple-ascending doses of ACT-1014-6470, an oral complement factor 5a receptor 1 (C5a 1 receptor) antagonist: Tolerability, pharmacokinetics and target engagement. British journal of clinical pharmacology (2022)
Daniel S Strasser, Sylvie Froidevaux, Virginie Sippel, Estelle Gerossier, Ursula Grieder, Gabin M Pierlot, Andrea Kieninger-Gräfitsch, Enrico Vezzali, Anna K Stalder, Bérengère Renault, Jesper Ryge, Aaron Hart, Ulrich Mentzel, Peter M A Groenen, Marcel P Keller, Marten Trendelenburg, Marianne M Martinic, Mark J Murphy
Preclinical to clinical translation of cenerimod, a novel S1P1 receptor modulator, in systemic lupus erythematosus. RMD open 6 (2) (2021)